SOPHiA GENETICS SA

SOPH

CH1125843347

Advanced Medical Equipment & Technology

Delayed Nasdaq Other stock markets 09:30:40 2026-03-11 am EDT			5-day change	1st Jan Change
4.440 ^USD	-1.11%		+5.09%	-4.93%

Mar. 03	SOPHiA GENETICS SA Reports Earnings Results for the Full Year Ended December 31, 2025	CI
Mar. 03	SOPHiA GENETICS SA, Q4 2025 Earnings Call, Mar 03, 2026

Sophia Genetics reports fourth quarter and full year 2025 results

Published on 03/03/2026 at 07:18 am EST

Reuters

This article is reserved for members

Unlock the article: REGISTER NOW!

100% Free Registration

Already a customer? Log In

Latest news about SOPHiA GENETICS SA

Mar. 03	SOPHiA GENETICS SA Reports Earnings Results for the Full Year Ended December 31, 2025	CI
Mar. 03	SOPHiA GENETICS SA, Q4 2025 Earnings Call, Mar 03, 2026
Mar. 03	SOPHiA GENETICS SA Reaffirms Earnings Guidance for the Fiscal Year 2026	CI
Mar. 03	Sophia Genetics reports fourth quarter and full year 2025 results	RE
Feb. 10	SOPHiA Genetics Announces Major Expansion in the United States with the Signing of Two Major Integrated Health Systems	CI
Jan. 28	Sophia Genetics Sa Announces Amendment to Credit Agreement with Additional Loan Tranches and Warrant Issuance	CI
Jan. 12	SOPHiA GENETICS SA Announces CEO Changes	CI
Jan. 12	Sophia Genetics Sa Appoints Kevin Puylaert as Chief Sales Officer, Effective January 2026	CI
Jan. 12	Sophia Genetics Sa Provides Earnings Guidance for 2026	CI
Jan. 12	SOPHiA GENETICS SA Announces Preliminary Unaudited Sales Results for Fourth Quarter and Year Ended December 31, 2025	CI
Jan. 07	Sophia Genetics and MD Anderson announce collaboration to accelerate AI-driven precision oncology	RE
Jan. 07	SOPHiA GENETICS and The University of Texas MD Anderson Cancer Center Announce Strategic Collaboration to Accelerate AI-Driven Precision Oncology	CI
Dec. 23	Swiss stocks - Factors to watch on December 23	RE
Nov. 11	Sophia Genetics and Complete Genomics Integrate Sequencing and Ai Analytics to Accelerate Adoption of Precision Medicine	CI
Nov. 11	Sophia Genetics, Complete Genomics Collaborate to Expand Access to Precision Oncology Testing	MT

Sophia Genetics SA is a Switzerland-based company engaged in the software publishing sector. The Company offer a cloud-based Software-as-a-Service platform - the SOPHiA DDM, which is data-driven medicine platform enabling insights from disparate, complex datasets to improve diagnosis, treatment, and drug development. The Company has offices in Switzerland, France and the United Kingdom and operates worldwide.

Employees

415

Sector

Advanced Medical Equipment & Technology

More about the company